Showing 1 - 20 results of 75 for search 'Doctors' trial', query time: 0.08s Refine Results
  1. 1

    Assessing the effect of On-site supportive communication training (On-site SCT) on doctor burnout: a randomized controlled trial by K.K. Antonsen, J.D. Lyhne, A.T. Johnsen, S. Eßer-Naumann, L.Ø. Poulsen, L. Lund, S. Timm, L.H. Jensen

    Published 2025-01-01
    “…Due to nine exclusions, data from 39 doctors in the intervention group and 41 doctors in the control group were available for analysis. …”
    Get full text
    Article
  2. 2

    Effects of community family doctors-led intervention for self-management and medication adherence in type 2 diabetes mellitus patients: study protocol of a cluster randomised controlled trial by Yue Chen, Biqi Ren, Ningsheng Wang, Shuang Lei, Shuzhi Lin, Lianye Liu, Yufang Xiang, Bianling Feng

    Published 2022-07-01
    “…This protocol describes a planned randomised controlled trial to evaluate the effectiveness of a family doctor-led intervention model for diabetes self-management and medication adherence in type 2 diabetes mellitus patients.Methods and analysis This is a Standard Protocol Items: Recommendations for Interventional Trials-compliant cluster randomised controlled trial. …”
    Get full text
    Article
  3. 3

    Knowledge on hydroxychloroquine prescription and attitude toward its use in COVID-19 – A survey-based study among doctors by T P Afra, N A Uvais, Anuradha Bishnoi, Edavalath Sukesh, Salin Eliyas, N A Bishurul Hafi, T Muhammed Razmi

    Published 2021-01-01
    “…Methods: An online survey was created with 8 knowledge-based questions (n = 2 fact-based [each scoring 1], n = 6 guideline-based [each scoring 2]), and 6 attitude-based questions, and distribution among a target population of doctors was done using Google™ forms. Results: Of 115 respondents, the majority considered HCQ a safe drug (86.1%) and were in favor of its usage in COVID-19 trials (81.7%) or health-care/contact prophylaxis (60.9%) but against its use as a mass prophylactic agent (80.9%). …”
    Get full text
    Article
  4. 4
  5. 5

    Metrics for Evaluating Telemedicine in Randomized Controlled Trials: Scoping Review by Yuka Sugawara, Yosuke Hirakawa, Masao Iwagami, Ryota Inokuchi, Rie Wakimizu, Masaomi Nangaku

    Published 2025-01-01
    “…Not only does telemedicine contribute to improved patient quality of life and satisfaction by reducing travel time and allowing patients to be seen in their usual environment, but it also has the potential to improve disease management by making it easier for patients to see a doctor. Recently, owing to IT developments, research on telemedicine has been increasing; however, its usefulness and limitations in randomized controlled trials remain unclear because of the multifaceted effects of telemedicine. …”
    Get full text
    Article
  6. 6
  7. 7
  8. 8

    Nurse management of minor problems in primary care emergencies: a non-randomized controlled trial by Jordi Estarlich-Corominas, Neus Soler-Abril, Anna Casanellas-Chuecos, Sara Becerra-Corzo, Andrea Sofia Bianco, Pere Torán-Monserrat, Rosa García-Sierra

    Published 2025-01-01
    “…Exactly half (156) were seen by nurses and half were seen by doctors. The experimental group had an average waiting time of 15.1 min and the control group 33.25 min. …”
    Get full text
    Article
  9. 9

    THE USE OF ARTIFICIAL INTELLIGENCE IN THE THERAPEUTIC MANAGEMENT OF PAPILLARY THYROID MICROCARCINOMA: A RANDOMIZED CONTROLLED TRIAL PROTOCOL by Ramona Elena Teiu, Tudor Florin Ursuleanu, Hlescu Cristian Stefan, Roxana Grigorovici, Andreea Roxana Luca, Maria Paula Comanescu, Alina Ionela Calin, Alexandru Grigorovici

    Published 2024-12-01
    “…I aim to use AI models to obtain correct and favorable results for the diagnosis and prognosis of papillary thyroid cancer by conducting a clinical trial, in which we will use the diagnostic method optimized by artificial intelligence (AI) algorithms.The use of AI will avoid errors and increase performance in the interpretation of the doctor’s computed tomography (CT) scan and consequently, improve treatment planning. …”
    Get full text
    Article
  10. 10

    Patient Perspectives on Evolving Diverticulitis Treatment: An Assessment of Patient Willingness to Enroll in a Randomized Controlled Trial by Annie Altman-Merino, MD, Kemberlee Bonnet, MA, David Schlundt, PhD, Jesse Wrenn, MD, PhD, Wesley H. Self, MD, MPH, Elisa J. Gordon, PhD, MPH, Alexander T. Hawkins, MD, MPH

    Published 2024-09-01
    “…In a survey of 218 subjects, 62% of respondents reported willingness to participate in a randomized clinical trial. “What my doctor thinks,” followed by “What I have experienced in the past” were the most important decision-making factors. …”
    Get full text
    Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    A randomised trial comparing the clinical effectiveness of different emergency department healthcare professionals in soft tissue injury management by Jonathan Richard Benger, Jane Powell, Fiona Cramp, Carey Middleton McClellan

    Published 2012-11-01
    “…Objectives To evaluate the clinical effectiveness of soft tissue injury management by emergency nurse practitioners (ENPs) and extended scope physiotherapists (ESPs) compared to the routine care provided by doctors in a UK emergency department (ED).Design Randomised, pragmatic trial of equivalence.Setting One adult ED in England.Participants 372 patients were randomised; 126 to the ESP group, 123 to the ENP group and 123 to the doctor group. …”
    Get full text
    Article
  16. 16

    Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study by Manuel R Blum, Patricia M Kearney, Rose Galvin, Christine Baumgartner, Anette Van Dorland, Stephen Byrne, Nicolas Rodondi, Simon P Mooijaart, Carol Sinnott, Rosalinde K E Poortvliet, Jacobijn Gussekloo, David O Riordan, Carole Elodie Aubert, Kieran A Walsh, Robert S Du Puy, J Wouter Jukema, Vera McCarthy, Elaine K Walsh, Tinh-Hai Collet, Olaf M Dekkers

    Published 2018-03-01
    “…Objectives To estimate and compare the prevalence and type of potentially inappropriate prescribing (PIP) and potential prescribing omissions (PPOs) among community-dwelling older adults (≥65 years) enrolled to a clinical trial in three European countries.Design A secondary analysis of the Thyroid Hormone Replacement for Subclinical Hypothyroidism Trial dataset.Participants A subset of 48/80 PIP and 22/34 PPOs indicators from the Screening Tool of Older Persons Prescriptions/Screening Tool to Alert doctors to Right Treatment (STOPP/START) V2 criteria were applied to prescribed medication data for 532/737 trial participants in Ireland, Switzerland and the Netherlands.Results The overall prevalence of PIP was lower in the Irish participants (8.7%) compared with the Swiss (16.7%) and Dutch (12.5%) participants (P=0.15) and was not statistically significant. …”
    Get full text
    Article
  17. 17
  18. 18

    Coke zero for the zero: A randomized controlled trial examining coke zero consumption on night call inpatient course and mortality by Yu Heng Kwan, Haoming Tang, Lihua Qi, Angela Frances Hui Wen Yap, Linxuan Yan, Yi Xin Li, Andrea Zhe Ern Lee, Antoinette Shui Wen Fong, Yarn Kit Chan, Feng Yi Low, Charmaine Wai Yan Sum, Benjamin Jun Jie Seng, Sungwon Yoon, Truls Østbye, Sheryl Shien Wen Gan, Haur Yueh Lee, Warren Fong

    Published 2025-01-01
    “…Methods A double-blinded randomized controlled trial was conducted in the Division of Medicine, Singapore General Hospital, Singapore involving junior doctors from January 2024 to February 2024.The primary outcome was the number of ward admissions under the night call doctor’s care. …”
    Get full text
    Article
  19. 19

    Protocol for process evaluation of SMART Mental Health cluster randomised control trial: an intervention for management of common mental disorders in India by Anushka Patel, David Peiris, Pallab K Maulik, Graham Thornicroft, Shekhar Saxena, Sudha Kallakuri, Amanpreet Kaur, Siddhardha Devarapalli, Mercian Daniel, Beverley M Essue, Shashi Kant, D Praveen, Usha Raman, Rajesh Sagar, Ankita Mukherjee

    Published 2022-06-01
    “…Quantitative data sources will include usage analytics extracted from the mHealth platform for the trial. Qualitative data sources will include focus group discussions and interviews with recruited participants, primary health centre doctors, community health workers (Accredited Social Health Activits) who participated in the project and local community leaders. …”
    Get full text
    Article
  20. 20